Option Care Health (NASDAQ:OPCH) Stock Price Expected to Rise, Barrington Research Analyst Says

Option Care Health (NASDAQ:OPCH) had its price objective raised by Barrington Research from $33.00 to $38.00 in a research note published on Thursday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock.

Several other brokerages have also recently commented on OPCH. Truist Financial decreased their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. JMP Securities restated a “market outperform” rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, JPMorgan Chase & Co. increased their price objective on Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, Option Care Health has an average rating of “Moderate Buy” and a consensus price target of $32.88.

Option Care Health Trading Up 0.2 %

Shares of Option Care Health stock opened at $33.20 on Thursday. The business has a fifty day simple moving average of $28.49 and a 200-day simple moving average of $28.07. The firm has a market cap of $5.65 billion, a price-to-earnings ratio of 27.90, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health has a fifty-two week low of $21.39 and a fifty-two week high of $34.17.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of OPCH. Murphy & Mullick Capital Management Corp acquired a new stake in Option Care Health during the 4th quarter valued at $26,000. UMB Bank n.a. lifted its holdings in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after buying an additional 346 shares in the last quarter. Signaturefd LLC boosted its position in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after acquiring an additional 1,005 shares during the period. Quadrant Capital Group LLC grew its stake in shares of Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after acquiring an additional 1,099 shares in the last quarter. Finally, Public Employees Retirement System of Ohio increased its position in Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock worth $43,000 after acquiring an additional 332 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.